KRAS and neoplasm: Our data additionally confirmed our own previous report of increased K-Ras mutation burden in advanced Dukes’ C tumours (Smith et al, 2002) and identified a novel association associating K-Ras mutations with the presence of lymph-node metastases, consistent with the hypothesis that the K-Ras mutation is associated with a more aggressive tumour phenotype.